Ignite Creation Date:
2025-12-24 @ 7:45 PM
Ignite Modification Date:
2026-01-13 @ 11:43 AM
Study NCT ID:
NCT00628303
Status:
WITHDRAWN
Last Update Posted:
2012-08-01
First Post:
2008-02-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 3 Trial of the Effect of Motavizumab Prophylaxis on Reduction of Serious Early Childhood Wheezing in Infants
Sponsor:
MedImmune LLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MI-CP169
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Hasan S. Jafri, M.D.
Old Organization:
MedImmune Inc.